Section II. The Dopamine System

International Review of Neurobiology

Volumn 64, Issue , 2005, Pages 123-172

  Smythies, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR;

ANIMAL; BRAIN; HISTOLOGY; HUMAN; NERVE TRACT; PHYSIOLOGY; REVIEW;

ANIMALS; BRAIN; DOPAMINE; HUMANS; NEURAL PATHWAYS; RECEPTORS, DOPAMINE;

EID: 24644464776     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(05)64002-0     Document Type: Review

References (286)

1. Abi-Dargham A., Martinez D., Mawlawi O., Simpson N., Hwang D.R., Slifstein M., Anjilvel S., Pidcock J., Guo N.N., Lombardo I., Mann J.J., Van Heertum R., Foged C., Halldin C., and Laruelle M. Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. Cereb. Blood Flow Metab. 20 (2000) 225-243
2. Adams A.C., and Keefe K.A. Examination of the involvement of protein kinase A in D2 dopamine receptor antagonist-induced immediate early gene expression. J. Neurochem. 77 (2001) 326-335
3. Ahn S., and Phillips A.G. Modulation by central and basolateral amygdalar nuclei of dopaminergic correlates of feeding to satiety in the rat nucleus accumbens and medial prefrontal cortex. J. Neurosci. 22 (2002) 10958-10965
4. Aizman O., Brismar H., Uhlen P., Zettergren E., Levey A.I., Forssberg H., Greengard P., and Aperia A. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat. Neurosci. 3 (2000) 226-230
5. Akirav I., and Richter-Levin G. Mechanisms of amygdala modulation of hippocampal plasticity. J. Neurosci. 22 (2002) 9912-9921
6. 2+)-responsible secretory vesicles through the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. J. Biochem. (Tokyo) 131 (2002) 887-894
7. Andersson M., Konradi C., and Cenci M.A. cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. J. Neurosci. 21 (2001) 9930-9943
8. Angenstein F., Matthies Jr. H., Staeck S., Reymann K.G., and Staak S. The maintenance of hippocampal long-term potentiation is paralleled by a dopamine-dependent increase in glycoprotein fucosylation. Neurochem. Int. 21 (1992) 403-408
9. Antunes F., Han D., Rettori D., and Cadenas E. Mitochondrial damage by nitric oxide is potentiated by dopamine in PC12 cells. Biochim. Biophys. Acta 1556 (2002) 233-238
10. Ariano M.A., Wang J., Noblett K.L., Larson E.R., and Sibley D.R. Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res. 752 (1997) 26-34
11. 2. J. Neurosci. 23 (2003) 2744-2750
12. Awenowicz P.W., and Porter L.L. Local application of dopamine inhibits pyramidal tract neuron activity in the rodent motor cortex. J. Neurophysiol. 88 (2002) 3439-3451
13. Baker D.A., Xi Z.X., Shen H., Swanson C.J., and Kalivas P.W. The origin and neuronal function of in vivo nonsynaptic glutamate. J. Neurosci. 22 (2002) 9134-9141
14. Banihashemi B., and Albert P.R. Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: Distinct Galpha and Gbetagamma requirements. Mol. Endocrinol. 16 (2002) 2393-2404
15. Baufreton J., Garret M., Rivera A., de la Calle A., Gonon F., Dufy B., Bioulac B., and Taupignon A. D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. J. Neurosci. 23 (2003) 816-825
16. Bergquist F., Niazi H.S., and Nissbrandt H. Evidence for different exocytosis pathways in dendritic and terminal dopamine release in vivo. Brain Res. 950 (2002) 245-253
17. Bergson C., Mrzljak L., Smiley J.F., Pappy M., Levenson R., and Goldman-Rakic P.S. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J. Neurosci. 15 (1995) 7821-7836
18. Berke J.D., Paletzki R.F., Aronson G.J., Hyman S.E., and Gerfen C.R. A complex program of striatal gene expression induced by dopaminergic stimulation. J. Neurosci. 18 (1998) 5301-5310
19. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience?. Brain Res. Brain Res. Rev. 28 (1998) 309-369
20. Beyer C., and Karolczak M. Estrogenic stimulation of neurite growth in midbrain dopaminergic neurons depends on cAMP/protein kinase A signalling. J. Neurosci. Res. 59 (2000) 107-116
21. Bissiere S., Humeau Y., and Luthi A. Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition. Nat. Neurosci. 6 (2003) 587-592
22. Black K.J., Hershey T., Gado M.H., and Perlmutter J.S. Dopamine D(1) agonist activates temporal lobe structures in primates. J. Neurophysiol. 84 (2000) 549-557
23. Blond O., Crepel F., and Otani S. Long-term potentiation in rat prefrontal slices facilitated by phased application of dopamine. Eur. J. Pharmacol. 438 (2002) 115-116
24. Bonanno G., Sala R., Cancedda L., Cavazzani P., Cossu M., and Raiteri M. Release of dopamine from human neocortex nerve terminals evoked by different stimuli involving extra- and intraterminal calcium. Br. J. Pharmacol. 129 (2000) 1780-1786
25. Bonci A., and Malenka R.C. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. J. Neurosci. 19 (1999) 3723-3730
26. Borrelli E. Dopamine D2 receptors: Key regulators of dopaminergic functions. J. Neurochem. 85 Suppl. 2 (2003) 5
27. Bouron A., and Reuter H. The D1 dopamine receptor agonist SKF-38393 stimulates the release of glutamate in the hippocampus. Neuroscience 94 (1999) 1063-1070
28. Bozzi Y., Vallone D., and Borrelli E. Neuroprotective role of dopamine against hippocampal cell death. J. Neurosci. 20 (2000) 8643-8649
29. Brami-Cherrier K., Valjent E., Garcia M., Pages C., Hipskind R.A., and Caboche J. Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: A new route to cAMP response element-binding protein phosphorylation. J. Neurosci. 22 (2002) 8911-8921
30. Caille I., Dumartin B., and Bloch B. Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation. Brain Res. 730 (1996) 17-31
31. Calabresi P., Gubellini P., Centonze D., Picconi B., Bernardi G., Chergui K., Svenningsson P., Fienberg A.A., and Greengard P. Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. J. Neurosci. 20 (2000) 8443-8451
32. Calabresi P., Saiardi A., Pisani A., Baik J.H., Centonze D., Mercuri N.B., Bernardi G., and Borrelli E. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J. Neurosci. 17 (1997) 4536-4544
33. + channels by D1-like dopamine receptors in rat hippocampal neurons. J. Neurosci. 19 (1999) 5301-5310
34. Carr D.B., O'Donnell P., Card J.P., and Sesack S.R. Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens. J. Neurosci. 19 (1999) 11049-11060
35. Carr D.B., and Sesack S.R. Dopamine terminals synapse on callosal projection neurons in the rat prefrontal cortex. J. Comp. Neurol. 425 (2000) 275-283
36. Castagne V.V., Rougemont M., Cuenod M., and Do K.Q. Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: Relevance to schizophrenia. Neurobiol. Dis. 15 (2004) 93-105
37. Castellani R., Smith M.A., Richey P.L., and Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res. 737 (1996) 195-200
38. Cathala L., and Paupardin-Tritsch D. Effect of catecholamines on the hyperpolarization-activated cationic Ih and the inwardly rectifying potassium I(Kir) currents in the rat substantia nigra pars compacta. Eur. J. Neurosci. 11 (1999) 398-406
39. Centonze D., Bracci E., Pisani A., Gubellini P., Bernardi G., and Calabresi P. Activation of dopamine D1-like receptors excites LTS interneurons of the striatum. Eur. J. Neurosci. 15 (2002) 2049-2052
40. Centonze D., Picconi B., Gubellini P., Bernardi G., and Calabresi P. Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur. J. Neurosci. 13 (2001) 1071-1077
41. Chang J.P., Abele J.T., Van Goor F., Wong A.O., and Neumann C.M. Role of arachidonic acid and calmodulin in mediating dopamine D1- and GnRH-stimulated growth hormone release in goldfish pituitary cells. Gen. Comp. Endocrinol. 102 (1996) 88-101
42. Chao C.C., Ma Y.L., Chu K.Y., and Lee E.H. Integrin alphav and NCAM mediate the effects of GDNF on DA neuron survival, outgrowth, DA turnover and motor activity in rats. Neurobiol. Aging 24 (2003) 105-116
43. Chao S.Z., Ariano M.A., Peterson D.A., and Wolf M.E. D1 dopamine receptor stimulation increases GluR1 surface expression in nucleus accumbens neurons. J. Neurochem. 83 (2002) 704-712
44. 2+ dependence and time course of somatodendritic dopamine release: Substantia nigra versus striatum. J. Neurosci. 21 (2001) 7841-7847
45. Chen B.T., and Rice M.E. Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area. J. Neurochem. 81 (2002) 158-169
46. Cheng F.C., Kuo J.S., Chia L.G., and Dryhurst G. Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: Possible markers for and potential insights into the pathoetiology of Parkinson's disease. J. Neural. Transm. 103 (1996) 433-446
47. Christian B.T., Narayanan T.K., Shi B., and Mukherjee J. Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(18)F]fallypride in nonhuman primates. Synapse 38 (2000) 71-79
48. Chuhma N., Zhang H., Masson J., Zhuang X., Sulzer D., Hen R., and Rayport S. Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses. J. Neurosci. 24 (2004) 972-981
49. Ciliax B.J., Drash G.W., Staley J.K., Haber S., Mobley C.J., Miller G.W., Mufson E.J., Mash D.C., and Levey A.I. Immunocytochemical localization of the dopamine transporter in human brain. J. Comp. Neurol. 409 (1999) 38-56
50. + channels. J. Neurophysiol. 87 (2002) 1046-1056
51. Coull J.T. Neural correlates of attention and arousal: Insights from electrophysiology, functional neuroimaging and psychopharmacology. Prog. Neurobiol. 55 (1998) 343-361
52. Cragg S.J., Nicholson C., Kume-Kick J., Tao L., and Rice M.E. Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. J. Neurophysiol. 85 (2001) 1761-1771
53. Czyrak A., Chocyk A., Mackowiak M., Fijal K., and Wedzony K. Distribution of dopamine D1 receptors in the nucleus paraventricularis of the hypothalamus in rats: An immunohistochemical study. Brain Res. Mol. Brain Res. 85 (2000) 209-217
54. Damier P., Hirsch E.C., Agid Y., and Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122 (1999) 1437-1448
55. Delforge J., Bottlaender M., Loc'h C., Dolle F., and Syrota A. Parametric images of the extrastriatal D2 receptor density obtained using a high-affinity ligand (FLB 457) and a double-saturation method. J. Cereb. Blood Flow Metab. 21 (2001) 1493-1503
56. Delforge J., Bottlaender M., Loc'h C., Guenther I., Fuseau C., Bendriem B., Syrota A., and Maziere B. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J. Cereb. Blood Flow Metab. 19 (1999) 533-546
57. Descarries L., Watkins K.C., Garcia S., Bosler O., and Doucet G. Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: A quantitative autoradiographic and immunocytochemical analysis. J. Comp. Neurol. 375 (1996) 167-186
58. Di Maio S., Grizenko N., and Joober R. Dopamine genes and attention-deficit hyperactivity disorder: A review. J Psychiatry Neurosci. 28 (2003) 27-38
59. Di Marzo V., Vial D., Sokoloff P., Schwartz J.C., and Piomelli D. Selection of alternative G-mediated signaling pathways at the dopamine D2 receptor by protein kinase C. J. Neurosci. 13 (1993) 4846-4853
60. Dong Y., and White F.J. Dopamine D1-class receptors selectively modulate a slowly inactivating potassium current in rat medial prefrontal cortex pyramidal neurons. J. Neurosci. 23 (2003) 2686-2695
61. Doreulee N., Sergeeva O.A., Yanovsky Y., Chepkova A.N., Selbach O., Godecke A., Schrader J., and Haas H.L. Cortico-striatal synaptic plasticity in endothelial nitric oxide synthase deficient mice. Brain Res. 964 (2003) 159-163
62. Dudman J.T., Eaton M.E., Rajadhyaksha A., Macias W., Taher M., Barczak A., Kameyama K., Huganir R., and Konradi C. Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J. Neurochem. 87 (2003) 922-934
63. Dumartin B., Caille I., Gonon F., and Bloch B. Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists. J. Neurosci. 18 (1998) 1650-1661
64. Ellenbroek B.A., Lubbers L.J., and Cools A.R. The role of hippocampal dopamine receptors in prepulse inhibition. Eur. J. Neurosci. 15 (2002) 1237-1243
65. Ennis M., Zhou F.M., Ciombor K.J., Aroniadou-Anderjaska V., Hayar A., Borrelli E., Zimmer L.A., Margolis F., and Shipley M.T. Dopamine D2 receptor-mediated presynaptic inhibition of olfactory nerve terminals. J. Neurophysiol. 86 (2001) 2986-2997
66. Erickson S.L., Sesack S.R., and Lewis D.A. Dopamine innervation of monkey entorhinal cortex: Postsynaptic targets of tyrosine hydroxylase-immunoreactive terminals. Synapse 36 (2000) 47-56
67. Erikson K.M., Jones B.C., and Beard J.L. Iron deficiency alters dopamine transporter functioning in rat striatum. J. Nutr. 130 (2000) 2831-2837
68. Falkenburger B.H., Barstow K.L., and Mintz I.M. Dendrodendritic inhibition through reversal of dopamine transport. Science 293 (2001) 2465-2470
69. Federici M., Natoli S., Bernardi G., and Mercuri N.B. Dopamine selectively reduces GABA(B) transmission onto dopaminergic neurones by an unconventional presynaptic action. J. Physiol. 540 (2002) 119-128
70. Fendt M., Schwienbacher I., and Koch M. Amygdaloid N-methyl-D-aspartate and gamma-aminobutyric acid(A) receptors regulate sensorimotor gating in a dopamine-dependent way in rats. Neuroscience 98 (2000) 55-60
71. Feng Z.H., Wang T.G., Li D.D., Fung P., Wilson B.C., Liu B., Ali S.F., Langenbach R., and Hon J.S. Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neurosci. Lett. 329 (2002) 354-358
72. Fisher H., and Braun J.E. Modulation of the SNARE core complex by dopamine. Can. J. Physiol. Pharmacol. 78 (2000) 856-859
73. Floran B., Barajas C., Floran L., Erlij D., and Aceves J. Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat. Neuroscience 115 (2002) 743-751
74. Flores G., Liang J.J., Sierra A., Martinez-Fong D., Quirion R., Aceves J., and Srivastava L.K. Expression of dopamine receptors in the subthalamic nucleus of the rat: Characterization using reverse-polymerase chain reaction and autoradiography. Neuroscience 9 (1999) 549-556
75. Floresco S.B., Todd C.L., and Grace A.A. Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons. J. Neurosci. 21 (2001) 4915-4922
76. Flores-Hernandez J., Cepeda C., Hernandez-Echeagaray E., Calvert C.R., Jokel E.S., Fienberg A.A., Greengard P., and Levine M.S. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: Role of D1 receptors and DARPP-32. J. Neurophysiol. 88 (2002) 3010-3020
77. Flores-Hernandez J., Hernandez S., Snyder G.L., Yan Z., Fienberg A.A., Moss S.J., Greengard P., and Surmeier D.J. D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade. J. Neurophysiol. 83 (2000) 2996-3004
78. Fowler S.C., Zarcone T.J., Vorontsova E., and Chen R. Motor and associative deficits in D2 dopamine receptor knockout mice. Int. J. Dev. Neurosci. 20 (2002) 309-321
79. Fudge J.L., and Haber S.N. The central nucleus of the amygdala projection to dopamine subpopulations in primates. Neuroscience 97 (2000) 479-494
80. Fudge J.L., and Haber S.N. Bed nucleus of the stria terminalis and extended amygdala inputs to dopamine subpopulations in primates. Neuroscience 104 (2001) 807-827
81. Galindo A., Del Arco A., and Mora F. Endogenous GABA potentiates the potassium-induced release of dopamine in striatum of the freely moving rat: A microdialysis study. Res. Bull. 50 (1999) 209-214
82. Gao H.M., Hong J.S., Zhang W., and Liu B. Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: Relevance to the etiology of Parkinson's disease. J. Neurosci. 23 (2003) 1228-1236
83. Gao W.J., and Goldman-Rakic P.S. Selective modulation of excitatory and inhibitory microcircuits by dopamine. Proc. Natl. Acad. Sci. USA 100 (2003) 2836-2841
84. Geurts M., Hermans E., and Maloteaux J.M. Opposite modulation of regulators of G protein signalling-2 RGS2 and RGS4 expression by dopamine receptors in the rat striatum. Neurosci. Lett. 333 (2002) 146-150
85. Gimenez-Llort L., Wang F.H., Ogren S.O., and Ferre S. Local dopaminergic modulation of the motor activity induced by N-methyl-D-aspartate receptor stimulation in the ventral hippocampus. Neuropsychopharmacology 26 (2002) 737-743
86. Gines S., Hillion J., Torvinen M., Le Crom S., Casado V., Canela E.I., Rondin S., Lew J.Y., Watson S., Zoli M., Agnati L.F., Verniera P., Lluis C., Ferre S., Fuxe K., and Franco R. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc. Natl. Acad. Sci. USA 97 (2000) 8606-8611
87. Giuffrida A., Parsons L.H., Kerr T.M., Rodriguez de Fonseca F., Navarro M., and Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 2 (1999) 358-363
88. Glavan G., Zorec R., Babic K., Sket D., and Zivin M. Dopaminergic regulation of synaptotagmin I and IV mRNAs in hemiparkinsonian rats. Neuroreport 11 (2000) 4043-4047
89. Goggi J., Pullar I.A., Carney S.L., and Bradford H.F. Signalling pathways involved in the short-term potentiation of dopamine release by BDNF. Brain Res. 968 (2003) 156-161
90. Gonzalez-Hernandez T., and Rodriguez M. Compartmental organization and chemical profile of dopaminergic and GABAergic neurons in the substantia nigra of the rat. J. Comp. Neurol. 421 (2000) 107-135
91. Gonzalez-Islas C., and Hablitz J.J. Dopamine inhibition of evoked IPSCs in rat prefrontal cortex. J. Neurophysiol. 86 (2001) 2911-2918
92. Gonzalez-Islas C., and Hablitz J.J. Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex. J. Neurosci. 23 (2003) 867-875
93. Gorelova N., Seamans J.K., and Yang C.R. Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J. Neurophysiol. 88 (2002) 3150-3166
94. Groc L., Jackson Hunter T., Jiang H., Bezin L., Koubi D., Corcoran G.B., and Levine R.A. Nitric oxide synthase inhibition during development: Effect on apoptotic death of dopamine neurons. Brain Res. Dev. Brain Res. 138 (2002) 147-153
95. Gu Q. Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity. Neuroscience 111 (2002) 815-835
96. Gulledge A.T., and Jaffe D.B. Multiple effects of dopamine on layer V pyramidal cell excitability in rat prefrontal cortex. J. Neurophysiol. 86 (2001) 586-595
97. Gurden H., Takita M., and Jay T.M. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. J. Neurosci. 20 (2000) RC106
98. Gurden H., Tassin J.P., and Jay T.M. Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex long-term potentiation. Neuroscience 94 (1999) 1019-1027
99. Gurevich E.V., Robertson R.T., and Joyce J.N. Thalamo-cortical afferents control transient expression of the dopamine D(3) receptor in the rat somatosensory cortex. Cereb. Cortex. 11 (2001) 691-701
100. Hagelberg N., Martikainen I.K., Mansikka H., Hinkka S., Nagren K., Hietala J., Scheinin H., and Pertovaara A. Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain 99 (2002) 273-279
101. Haj-Dahmane S. D2-like dopamine receptor activation excites rat dorsal raphe 5-HT neurons in vitro. Eur. J. Neurosci. 14 (2001) 125-134
102. Hall F.S., Wilkinson L.S., Humby T., and Robbins T.W. Maternal deprivation of neonatal rats produces enduring changes in dopamine function. Synapse 32 (1999) 37-43
103. Hasue R.H., and Shammah-Lagnado S.J. Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: A combined retrograde tracing and immunohistochemical study in the rat. J. Comp. Neurol. 454 (2002) 15-33
104. Hauber W., and Fuchs H. Dopamine release in the rat globus pallidus characterised by in vivo microdialysis. Behav. Brain Res. 111 (2000) 39-44
105. Haughey H.M., Brown J.M., Fleckenstein A.E., and Hanson G.R. Oxygen radicals differentially affect Na+/Cl(-)-dependent transporters. Eur. J. Pharmacol. 379 (1999) 107-110
106. Henderson J.M., Carpenter K., Cartwright H., and Halliday G.M. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: Clinical and therapeutic implications. Brain 123 (2000) 1410-1421
107. Henze D.A., Gonzalez-Burgos G.R., Urban N.N., Lewis D.A., and Barrionuevo G. Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex. J. Neurophysiol. 84 (2000) 2799-2809
108. 2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. J. Neurosci. 20 (2000) 8987-8995
109. Hersch S.M., Ciliax B.J., Gutekunst C.A., Rees H.D., Heilman C.J., Yung K.K., Bolam J.P., Ince E., Yi H., and Levey A.I. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J. Neurosci. 15 (1995) 5222-5237
110. Hersch S.M., Yi H., Heilman C.J., Edwards R.H., and Levey A.I. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J. Comp. Neurol. 388 (1997) 211-227
111. Hidaka S., and Totterdell S. Ultrastructural features of the nitric oxide synthase-containing interneurons in the nucleus accumbens and their relationship with tyrosine hydroxylase-containing terminals. J. Comp. Neurol. 431 (2001) 139-154
112. Hirrlinger J., Schulz J.B., and Dringen R. Effects of dopamine on the glutathione metabolism of cultured astroglial cells: Implications for Parkinson's disease. J. Neurochem. 82 (2002) 458-467
113. Hoffman D.A., and Johnston D. Neuromodulation of dendritic action potentials. J. Neurophysiol. 81 (1999) 408-411
114. Hollon T.R., Bek M.J., Lachowicz J.E., Ariano M.A., Mezey E., Ramachandran R., Wersinger S.R., Soares-da-Silva P., Liu Z.F., Grinberg A., Drago J., Young III W.S., Westphal H., Jose P.A., and Sibley D.R. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J. Neurosci. 22 (2002) 10801-10810
115. Horvitz J.C. Dopamine gating of glutamatergic sensorimotor and incentive motivational input signals to the striatum. Behav. Brain Res. 137 (2002) 65-74
116. 2+)-calmodulin-dependent protein kinase II activity in rat hippocampal slices. Zhongguo Yao Li Xue Bao 20 (1999) 902-906
117. Howland J.G., Taepavarapruk P., and Phillips A.G. Glutamate receptor-dependent modulation of dopamine efflux in the nucleus accumbens by basolateral, but not central, nucleus of the amygdala in rats. J. Neurosci. 22 (2002) 1137-1145
118. Hu G., Duffy P., Swanson C., Ghasemzadeh M.B., and Kalivas P.W. The regulation of dopamine transmission by metabotropic glutamate receptors. J. Pharmacol. Exp. Ther. 289 (1999) 412-416
119. Huda K., and Matsunami K. Influence of dopamine on ventrolateral thalamic inputs in cat motor cortex. Brain Res. 963 (2003) 178-189
120. Huda K., Salunga T.L., and Matsunami K. Dopaminergic inhibition of excitatory inputs onto pyramidal tract neurons in cat motor cortex. Neurosci. Lett. 307 (2001) 175-178
121. Ikemoto K., Satoh K., Kitahama K., Geffard M., and Maeda T. Electron-microscopic study of dopaminergic structures in the medial subdivision of the monkey nucleus accumbens. Brain Res. 111 (1996) 41-50
122. Iravani M.M., Kashefi K., Mander P., Rose S., and Jenner P. Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience 110 (2002) 49-58
123. Ishige K., Chen Q., Sagara Y., and Schubert D. The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death. J. Neurosci. 21 (2001) 6069-6076
124. Itoh K., Weis S., Mehraein P., and Muller-Hocker J. Cytochrome c oxidase defects of the human substantia nigra in normal aging. Neurobiol. Aging 17 (1996) 843-848
125. Jackson M.E., and Moghaddam B. Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. J. Neurosci. 21 (2001) 676-681
126. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 3 53 Suppl (2003) S26-S36
127. Jenner P., and Olanow C.W. Understanding cell death in Parkinson's disease. Ann. Neurol. 44 Suppl. 1 (1998) S72-S84
128. Jin L.Q., Wang H.Y., and Friedman E. Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions. J. Neurochem. 78 (2001) 981-990
129. Jin L.Q., Cai G., Wang H.Y., Smith C., and Friedman E. Characterization of the phosphoinositide-linked dopamine receptor in a mouse hippocampal-neuroblastoma hybrid cell line. J. Neurochem. 71 (1998) 1935-1943
130. Joel D., and Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: An analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96 (2000) 451-474
131. Junn E., and Mouradian M.M. Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine. Neurosci. Lett. 320 (2002) 146-150
132. Kaasinen V., Vilkman H., Hietala J., Nagren K., Helenius H., Olsson H., Farde L., and Rinne J. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiol. Aging 21 (2000) 683-688
133. Kang D.K., Kim K.O., Lee S.H., Lee Y.S., and Son H. c-Fos expression by. Mol. Cells 10 (2000) 546-551
134. Katayama J., Akaike N., and Nabekura J. Characterization of pre- and post-synaptic metabotropic glutamate receptor-mediated inhibitory responses in substantia nigra dopamine neurons. Neurosci. Res. 45 (2003) 101-115
135. Khan Z.U., Gutierrez A., Martin R., Penafiel A., Rivera A., and de la Calle A. Dopamine D5 receptors of rat and human brain. Neuroscience 100 (2000) 689-699
136. Kihara T., Shimohama S., Sawada H., Honda K., Nakamizo T., Kanki R., Yamashita H., and Akaike A. Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade. J. Neurosci. Res. 70 (2002) 274-282
137. Kim K.M., Valenzano K.J., Robinson S.R., Yao W.D., Barak L.S., and Caron M.G. Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J. Biol. Chem. 276 (2001) 37409-37414
138. Kinor N., Geffen R., Golomb E., Zinman T., and Yadid G. Dopamine increases glial cell line-derived neurotrophic factor in human fetal astrocytes. Glia 33 (2001) 143-150
139. Kiss J.P., Hennings E.C., Zsilla G., and Vizi E.S. A possible role of nitric oxide in the regulation of dopamine transporter function in the striatum. Neurochem. Int. 34 (1999) 345-350
140. Ko F., Seeman P., Sun W.S., and Kapur S. Dopamine D2 receptors internalize in their low-affinity state. Neuroreport 13 (2002) 1017-1020
141. Kostrzewa R.M., Kostrzewa J.P., and Brus R. Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum. Amino Acids 19 (2000) 183-199
142. Kotecha S.A., Oak J.N., Jackson M.F., Perez Y., Orser B.A., Van Tol H.H., and Mac Donald J.F. A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 35 (2002) 1111-1122
143. Kulla A., and Manahan-Vaughan D. Depotentiation in the dentate gyrus of freely moving rats is modulated by D1/D5 dopamine receptors. Cereb. Cortex. 10 (2000) 614-620
144. Kusuki T., Imahori Y., Ueda S., and Inokuchi K. Dopaminergic modulation of LTP induction in the dentate gyrus of intact brain. Neuroreport 8 (1997) 2037-2040
145. Kuzhikandathil E.V., and Oxford G.S. Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells. J. Neurosci. 19 (1999) 1698-1707
146. La Hoste G.J., Henry B.L., and Marshall J.F. Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials. J. Neurosci. 20 (2000) 6666-6671
147. Lara J., Kusano K., House S., and Gainer H. Interactions of cyclic adenosine monophosphate, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor treatment on the survival and growth of postnatal mesencephalic dopamine neurons in vitro. Exp. Neurol. 180 (2003) 32-45
148. Lavin A., and Grace A.A. Stimulation of D1-type dopamine receptors enhances excitability in prefrontal cortical pyramidal neurons in a state-dependent manner. Neuroscience 104 (2001) 335-346
149. Law-Tho D., Desce J.M., and Crepel F. Dopamine favours the emergence of long-term depression versus long-term potentiation in slices of rat prefrontal cortex. Neurosci. Lett. 188 (1995) 125-128
150. Lee D., Huang W., and Lim A.T. Dopamine induces a biphasic modulation of hypothalamic ANF neurons: A ligand concentration-dependent effect involving D5 and D2 receptor interaction. Mol. Psychiatry 5 (2000) 39-48
151. Legault M., and Wise R.A. Novelty-evoked elevations of nucleus accumbens dopamine: Dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission in the ventral tegmental area. Eur. J. Neurosci. 13 (2001) 819-828
152. Levant B. Differential distribution of D3 dopamine receptors in the brains of several mammalian species. Brain Res. 800 (1998) 269-274
153. Levin B.E. Glucose-regulated dopamine release from substantia nigra neurons. Brain Res. 874 (2000) 158-164
154. Lewis B.L., and O'Donnell P. Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential 'up' states in pyramidal neurons via D(1) dopamine receptors. Cereb. Cortex. 10 (2000) 1168-1175
155. Lezcano N., and Bergson C. D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons. J. Neurophysiol. 87 (2002) 2167-2175
156. L'hirondel M., Cheramy A., Godeheu G., and Glowinski J. Effects of arachidonic acid on dopamine synthesis, spontaneous release, and uptake in striatal synaptosomes from the rat. J. Neurochem. 64 (1995) 1406-1409
157. L'hirondel M., Cheramy A., Artaud F., Godeheu G., and Glowinski J. Contribution of endogenously formed arachidonic acid in the presynaptic facilitatory effects of NMDA and carbachol on dopamine release in the mouse striatum. Eur. J. Neurosci. 11 (1999) 1292-1300
158. Lin A.M. Recovery by NO of the iron-attenuated dopamine dynamics in nigrostriatal system of rat brain. Neurosci. Res. 34 (1999) 133-139
159. Lin R., Karpa K., Kabbani N., Goldman-Rakic P., and Levenson R. Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A. Proc. Natl. Acad. Sci. USA 98 (2001) 5258-5263
160. Lindgren N., Goiny M., Herrera-Marschitz M., Haycock J.W., Hokfelt T., and Fisone G. Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brain. Eur. J. Neurosci. 15 (2002) 769-773
161. Lindgren N., Usiello A., Goiny M., Haycock J., Erbs E., Greengard P., Hokfelt T., Borrelli E., and Fison G. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc. Natl. Acad. Sci. USA 100 (2003) 4305-4309
162. Lindgren N., Xu Z.Q., Herrera-Marschitz M., Haycock J., Hokfelt T., and Fisone G. Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum. Eur. J. Neurosci. 13 (2001) 773-780
163. Lindskog M., Svenningsson P., Fredholm B.B., Greengard P., and Fisone G. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Neuroscience 88 (1999) 1005-1008
164. Lin J.Y., Dubey R., Funk G.D., and Lipski J. Receptor subtype-specific modulation by dopamine of glutamatergic responses in striatal medium spiny neurons. Brain Res. 959 (2003) 251-262
165. Liu J.C., Baker R.E., Sun C., Sundmark V.C., and Elsholtz H.P. Activation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. A key step in the transcriptional suppression of the prolactin gene. J. Biol. Chem. 277 (2002) 35819-35825
166. Liu L.X., Burgess L.H., Gonzalez A.M., Sibley D.R., and Chiodo L.A. D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 mesencephalon hybrid cell (MES-23.5) via distinct G proteins. Synapse 31 (1999) 108-118
167. Liu J., and Mori A. Monoamine metabolism provides an antioxidant defense in the brain against oxidant- and free radical-induced damage. Arch. Biochem. Biophys. 302 (1993) 118-127
168. Liu Z., Zhang J., Fei J., and Guo L. A novel mechanism of dopamine neurotoxicity involving the peripheral extracellular and the plasma membrane dopamine transporter. Neuroreport 12 (2001) 3293-3297
169. Lotharius J., and Brundin P. Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease. Hum. Mol. Genet. 11 (2002) 2395-2407
170. Luo Y., Kokkonen G.C., Hattori A., Chrest F.J., and Roth G.S. Dopamine stimulates redox-tyrosine kinase signaling and p38 MAPK in activation of astrocytic C6-D2L cells. Brain Res. 850 (1999) 21-38
171. Maeda T., Kitahama K., and Geffard M. Dopaminergic innervation of rat locus coeruleus: A light and electron microscopic immunohistochemical study. Microsc. Res. Tech. 29 (1994) 211-218
172. Manahan-Vaughan D., and Kulla A. Regulation of depotentiation and long-term potentiation in the dentate gyrus of freely moving rats by dopamine D2-like receptors. Cereb. Cortex. 13 (2003) 123-135
173. Mansvelder H.D., Lodder J.C., Sons M.S., and Kits K.S. Dopamine modulates exocytosis independent of Ca(2+) entry in melanotropic cells. J. Neurophysiol. 87 (2002) 793-801
174. Matsumoto N., Minamimoto T., Graybiel A.M., and Kimura M. Neurons in the thalamic CM-Pf complex supply striatal neurons with information about behaviorally significant sensory events. J. Neurophysiol. 85 (2001) 960-976
175. Mattammal M.B., Strong R., Lakshmi V.M., Chung H.D., and Stephenson A.H. Prostaglandin H synthetase-mediated metabolism of dopamine: Implication for Parkinson's disease. J. Neurochem. 64 (1995) 1645-1654
176. Maurice N., Tkatch T., Meisler M., Sprunger L.K., and Surmeier D.J. D1/D5 dopamine receptor activation differentially modulates rapidly inactivating and persistent sodium currents in prefrontal cortex pyramidal neurons. J. Neurosci. 21 (2001) 2268-2277
177. Medina S., Martinez M., and Hernanz A. Antioxidants inhibit the human cortical neuron apoptosis induced by hydrogen peroxide, tumor necrosis factor alpha, dopamine and beta-amyloid peptide 1-42. Free Radic. Res. 36 (2002) 1179-1184
178. Mei Y.A. High-voltage-activated calcium current and its modulation by dopamine D4 and pituitary adenylate cyclase activating polypeptide receptors in cerebellar granule cells. Zhongguo Yao Li Xue Bao 20 (1999) 3-9
179. Merad-Boudia M., Nicole A., Santiard-Baron D., Saille C., and Ceballos-Picot I. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: Relevance to Parkinson's disease. Biochem. Pharmacol. 56 (1998) 645-655
180. Mercier D., Falardeau P., and Levesque D. Autoreceptor preference of dopamine D2 receptor agonists correlates with preferential coupling to cyclic AMP. Neuroreport 12 (2001) 1473-1479
181. Meredith G.E., Ypma P., and Zahm D.S. Effects of dopamine depletion on the morphology of medium spiny neurons in the shell and core of the rat nucleus accumbens. J. Neurosci. 15 (1995) 3808-3820
182. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Chui D.H., and Tabira T. Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction. J. Neurosci. 20 (2000) 1568-1574
183. Momiyama T., and Koga E. Dopamine D(2)-like receptors selectively block N-type Ca(2+) channels to reduce GABA release onto rat striatal cholinergic interneurones. J. Physiol. 533 (2001) 479-492
184. Morikawa H., Imani F., Khodakhah K., and Williams J.T. Inositol 1,4,5-triphosphate-evoked responses in midbrain dopamine neurons. J. Neurosci. 20 (2000) RC103
185. Muriel M.P., Agid Y., and Hirsch E. Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease. Mov. Disord. 16 (2001) 435-441
186. Nakamura K., Wang W., and Kang U.J. The role of glutathione in dopaminergic neuronal survival. J. Neurochem. 69 (1997) 1850-1858
187. Napolitano M., Centonze D., Calce A., Picconi B., Spiezia S., Gulino A., Bernardi G., and Calabresi P. Experimental Parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum. Neurobiol. Dis. 10 (2002) 387-395
188. Nappi A.J., and Vass E. The effects of nitric oxide on the oxidations of l-dopa and dopamine mediated by tyrosinase and peroxidase. J. Biol. Chem. 276 (2001) 11214-11222
189. Nguyen B., Carbajal M.E., and Vitale M.L. Intracellular mechanisms involved in dopamine-induced actin cytoskeleton organization and maintenance of a round phenotype in cultured rat lactotrope cells. Endocrinology 140 (1999) 3467-3477
190. Neusch C., Bohme V., Riesland N., Althaus M., and Moser A. The dopamine D2 receptor agonist alpha-dihydroergocryptine modulates voltage-gated sodium channels in the rat caudate-putamen. J. Neural Transm. 107 (2000) 531-541
191. Nishi A., Bibb J.A., Snyder G.L., Higashi H., Nairn A.C., and Greengard P. Amplification of dopaminergic signaling by a positive feedback loop. Proc. Natl. Acad. Sci. USA 97 (2000) 12840-12845
192. Nishikawa S., Goto S., Yamada K., Hamasaki T., and Ushio Y. Lack of Reelin causes malpositioning of nigral dopaminergic neurons: Evidence from comparison of normal and Reln(rl) mutant mice. J. Comp. Neurol. 461 (2003) 166-173
193. Okubo Y., Olsson H., Ito H., Lofti M., Suhara T., Halldin C., and Farde L. PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457. Neuroimage 10 (1999) 666-674
194. Otmakhova N.A., and Lisman J.E. D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. J. Neurosci. 16 (1996) 7478-7486
195. Otmakhova N.A., and Lisman J.E. D1/D5 dopamine receptors inhibit depotentiation at CA1 synapses via cAMP-dependent mechanism. J. Neurosci. 18 (1998) 1270-1279
196. Otani S., Auclair N., Desce J.M., Roisin M.P., and Crepel F. Dopamine receptors and groups I and II mGluRs cooperate for long-term depression induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases. J. Neurosci. 19 (1999) 9788-9802
197. Ozaki T. Comparative effects of dopamine D(1) and D(2) receptor antagonists on nerve growth factor protein induction. Eur. J. Pharmacol. 402 (2000) 39-44
198. Paolillo M., Montecucco A., Zanassi P., and Schinelli S. Potentiation of dopamine-induced cAMP formation by group I metabotropic glutamate receptors via protein kinase C in cultured striatal neurons. Eur. J. Neurosci. 10 (1998) 1937-1945
199. Paul S., Snyder G.L., Yokakura H., Picciotto M.R., Nairn A.C., and Lombroso P.J. The Dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway. J. Neurosci. 20 (2000) 5630-5638
200. Pearce R.K., Owen A., Daniel S., Jenner P., and Marsden C.D. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J. Neural. Transm. 104 (1997) 661-677
201. Pei L., Lee F.J., Moszczynska A., Vukusic B., and Liu F. Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. J. Neurosci. 24 (2004) 1149-1158
202. Petersen A.A., Larsen K.E., Behr G.G., Romero N., Przedborski S., Brundin P., and Sulzer D. Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death. Brain Res. Bull. 56 (2001) 331-335
203. Phillips A.G., Ahn S., and Howland J.G. Amygdalar control of the mesocorticolimbic dopamine system: Parallel pathways to motivated behavior. Neurosci. Biobehav. Rev. 27 (2003) 543-554
204. Phillips A.G., Ahn S., and Floresco S.B. Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task. J. Neurosci. 24 (2004) 547-553
205. Phillips P.E., and Stamford J.A. Differential recruitment of N-, P- and Q-type voltage-operated calcium channels in striatal dopamine release evoked by 'regular' and 'burst' firing. Brain Res. 884 (2000) 139-146
206. Pinto A., Jankowski M., and Sesack S.R. Projections from the paraventricular nucleus of the thalamus to the rat prefrontal cortex and nucleus accumbens shell: Ultrastructural characteristics and spatial relationships with dopamine afferents. J. Comp. Neurol. 459 (2003) 142-155
207. Piomelli D., Pilon C., Giros B., Sokoloff P., Martres M.P., and Schwartz J.C. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 353 (1991) 164-167
208. Pisani A., Bonsi P., Centonze D., Calabresi P., and Bernardi G. Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. J. Neurosci. 20 (2000) RC69
209. Porat S., Premkumar A., and Simantov R. Dopamine induces phenotypic differentiation or apoptosis in a dose-dependent fashion: Involvement of the dopamine transporter and p53. Dev. Neurosci. 23 (2001) 432-440
210. Pothos E.N. Regulation of dopamine quantal size in midbrain and hippocampal neurons. Behav. Brain Res. 10 (2002) 203-207
211. Price C.J., Kim P., and Raymond L.A. D1 dopamine receptor-induced cyclic AMP-dependent protein kinase phosphorylation and potentiation of striatal glutamate receptors. J. Neurochem. 73 (1999) 2441-2446
212. Prikhojan A., Brannan T., and Yahr M.D. Intrastriatal iron perfusion releases dopamine: An in-vivo microdialysis study. J. Neural Transm. 109 (2002) 645-649
213. Pubill D., Verdaguer E., Sureda F.X., Camins A., Pallas M., Camarasa J., and Escubedo E. Carnosine prevents methamphetamine-induced gliosis but not dopamine terminal loss in rats. Eur. J. Pharmacol. 448 (2002) 165-168
214. Rasolonjanahary R., Gerard C., Dufour M.N., Homburger V., Enjalbert A., and Guillon G. Evidence for a direct negative coupling between dopamine-D2 receptors and PLC by heterotrimeric Gi1/2 proteins in rat anterior pituitary cell membranes. Endocrinology 143 (2002) 747-754
215. Reynolds J.N., and Wickens J.R. Substantia nigra dopamine regulates synaptic plasticity and membrane potential fluctuations in the rat neostriatum, in vivo. Neuroscience 99 (2000) 199-203
216. Reynolds J.N., and Wickens J.R. Dopamine-dependent plasticity of corticostriatal synapses. Neural Netw. 15 (2002) 507-521
217. Roberson E.D., English J.D., Adams J.P., Selcher J.C., Kondratick C., and Sweatt J.D. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J. Neurosci. 19 (1999) 4337-4348
218. Roitman M.F., Stuber G.D., Phillips P.E., Wightman R.M., and Carelli R.M. Dopamine operates as a subsecond modulator of food seeking. J. Neurosci. 24 (2004) 1265-1271
219. Romanides A.J., Duffy P., and Kalivas P.W. Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats. Neuroscience 92 (1999) 97-106
220. Rose S., Hindmarsh J.G., and Jenner P. Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatum. J. Neural Transm. 106 (1999) 477-484
221. Rosenkranz J.A., and Grace A.A. Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J. Neurosci. 21 (2001) 4090-4103
222. Rubinstein M., Cepeda C., Hurst R.S., Flores-Hernandez J., Ariano M.A., Falzone T.L., Kozell L.B., Meshul C.K., Bunzow J.R., Low M.J., Levine M.S., and Grandy D.K. Dopamine D4 receptor-deficient mice display cortical hyperexcitability. J. Neurosci. 21 (2001) 3756-3763
223. Sanz A.G., Badia A., and Clos M.V. Role of calcium on the modulation of spontaneous acetylcholine efflux by the D2 dopamine receptor subtype in rat striatal synaptosomes. Brain Res. 854 (2000) 42-47
224. Saulle E., Centonze D., Martin A.B., Moratalla R., Bernardi G., and Calabresi P. Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors. Stroke 33 (2002) 2978-2984
225. Saul'skaya N.B., Mikhailova M.O., and Gorbachevskaya A.I. Dopamine-dependent inhibition of glycine release in the nucleus accumbens of the rat brain during food consumption. Neurosci. Behav. Physiol. 31 (2001) 317-321
226. Sawada H., Ibi M., Kihara T., Urushitani M., Akaike A., Kimura J., and Shimohama S. Dopamine D2-type agonists protect mesencephalic neurons against glutamate neurotoxicity: Mechanisms of neuroprotective treatment against oxidative stress. Ann. Neurol. 44 (1998) 110-119
227. Schoffelmeer A.N., Vanderschuren L.J., De Vries T.J., Hogenboom F., Wardeh G., and Mulder A.H. Synergistically interacting dopamine D1 and NMDA receptors mediate nonvesicular transporter-dependent GABA release from rat striatal medium spiny neurons. J. Neurosci. 20 (2000) 3496-3503
228. Schultz W.J. Predictive reward signal of dopamine neurons. J. Neurophysiol. 80 (1998) 1-17
229. Schurov I.L., Hepworth T.J., and Hastings M.H. Dopaminergic signalling in the rodent neonatal suprachiasmatic nucleus identifies a role for protein kinase A and mitogen-activated protein kinase in circadian entrainment. Eur. J. Neurosci. 15 (2002) 223-232
230. Scott L., Kruse M.S., Forssberg H., Brismar H., Greengard P., and Aperia A. Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation. Proc. Natl. Acad. Sci. USA 99 (2002) 1661-1664
231. Seamans J.K., Gorelova N., Durstewitz D., and Yang C.R. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J. Neurosci. 21 (2001) 3628-3638
232. Seeman P., and Tallerico T. Link between dopamine D1 and D2 receptors in rat and human striatal tissues. Synapse 47 (2003) 250-254
233. Segieth J., Fowler L., Whitton P., and Pearce B. Nitric oxide-mediated regulation of dopamine release in the hippocampus in vivo. Neuropharmacology 39 (2000) 571-577
234. Sesack S.R., Carr D.B., Omelchenko N., and Pinto A. Anatomical substrates for glutamate-dopamine interactions: Evidence for specificity of connections and extrasynaptic actions. Ann. N. Y. Acad. Sci. 1003 (2003) 36-52
235. Sesack S.R., Snyder C.L., and Lewis D.A. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J. Comp. Neurol. 363 (1995) 264-280
236. Seutin V., Massotte L., Renette M.F., and Dresse A. Evidence for a modulatory role of Ih on the firing of a subgroup of midbrain dopamine neurons. Neuroreport. 12 (2001) 255-258
237. Seutin V., Mkahli F., Massotte L., and Dresse A. Calcium release from internal stores is required for the generation of spontaneous hyperpolarizations in dopaminergic neurons of neonatal rats. J. Neurophysiol. 83 (2000) 192-197
238. Schapira A.H., Mann V.M., Cooper J.M., Krige D., Jenner P.J., and Marsden C.D. Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol. 32 Suppl (1992) S116-S124
239. Shen X.M., and Dryhurst G. Further insights into the influence of L-cysteine on the oxidation chemistry of dopamine: Reaction pathways of potential relevance to Parkinson's disease. Chem. Res. Toxicol. 9 (1996) 751-763
240. Smidt M.P., Smits S.M., and Burbach J.P. Molecular mechanisms underlying midbrain dopamine neuron development and function. Eur. J. Pharmacol. 480 (2003) 75-88
241. Smiley J.F., Levey A.I., Ciliax B.J., and Goldman-Rakic P.S. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: Predominant and extrasynaptic localization in dendritic spines. Proc. Natl. Acad. Sci. USA 91 (1994) 5720-5724
242. Smith J.C., and Whitton P.S. The regulation of NMDA-evoked dopamine release by nitric oxide in the frontal cortex and raphe nuclei of the freely moving rat. Brain Res. 889 (2001) 57-62
243. Smith S., and Ramirez V.D. Direct visualization of internalization and intracellular trafficking of dopamine-releasing protein-36aa. Neuroendocrinology 75 (2002) 98-112
244. Smith-Roe S.L., and Kelley A.E. Coincident activation of NMDA and dopamine D1 receptors within the nucleus accumbens core is required for appetitive instrumental learning. J. Neurosci. 20 (2000) 7737-7742
245. Smythies J. On the function of neuromelanin. Proc. R. Soc. London Biol. Sci. 263 (1996) 487-489
246. Smythies J. The biochemical basis of synaptic plasticity and neurocomputation: A new theory. Proc. R. Soc. London Biol. Sci. 264 (1997) 575-579
247. Smythies J. The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: Functional interrelationships in health and disease: A review-discussion. Neurotox. Res. 1 (1999) 27-39
248. Smythies J. The neurochemical basis of learning and neurocomputation: The redox theory. Behav. Brain Res. 99 (1999) 1-6
249. Smythies J. Schizophrenia. Intern. Rev. Neurobiol. Vol. 59 (2004), Academic Press, San Diego
250. Snyder G.L., Allen P.B., Fienberg A.A., Valle C.G., Huganir R.L., Nairn A.C., and Greengard P. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J. Neurosci. 20 (2000) 4480-4488
251. Song Z.M., Undie A.S., Koh P.O., Fang Y.Y., Zhang L., Dracheva S., Sealfon S.C., and Lidow M.S. D1 dopamine receptor regulation of microtubule-associated protein-2 phosphorylation in developing cerebral cortical neurons. J. Neurosci. 22 (2002) 6092-6105
252. Stefani A., Spadoni F., Martorana A., Lavaroni F., Martella G., Sancesario G., and Bernardi G. D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation. Eur. J. Neurosci. 15 (2002) 815-825
253. Storozhuk V.M., Khorevin V.I., Rozumna N.M., Villa A.E., and Tetko I.V. Dopamine modulation of activity of cat sensorimotor cortex neurons during conditioned reflexes. Neurosci. Lett. 330 (2002) 171-174
254. Sugahara M., and Shiraishi H. Synaptic density of the prefrontal cortex regulated by dopamine instead of serotonin in rats. Brain Res. 814 (1998) 143-156
255. Suzuki T., Miura M., Nishimura K., and Aosaki T. Dopamine-dependent synaptic plasticity in the striatal cholinergic interneurons. J. Neurosci. 21 (2001) 6492-6501
256. Svenningsson P., Nishi A., Fisone G., Girault J.A., Nairn A.C., and Greengard P. DARPP-32: An integrator of neurotransmission. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 2692-2696
257. Svingos A.L., Periasamy S., and Pickel V.M. Presynaptic dopamine D(4) receptor localization in the rat nucleus accumbens shell. Synapse 36 (2000) 222-232
258. 2+)/calmodulin-dependent protein kinase II and brain-derived neurotrophic factor gene expression by stimulation of dopamine D2 receptor in transfected NG108-15 cells. J. Neurochem. 82 (2002) 316-328
259. Tang K., Low M.J., Grandy D.K., and Lovinger D.M. Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc. Natl. Acad. Sci. USA 98 (2001) 1255-1260
260. Tang F.M., Sun Y.F., Wang R., Ding Y.M., Zhang G.Y., and Jin G.Z. Dopamine-glutamate interaction in rat striatal slices: Changes of CCDPK II, PKA, and LDH activity by receptor-mediated mechanisms. Acta Pharmacol. Sin. 21 (2000) 145-150
261. Taymans J.M., Leysen J.E., and Langlois X. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: Clues for RGS2 and RGS4 functions. J. Neurochem. 84 (2003) 1118-1127
262. Teismann P., Tieu K., Choi D.K., Wu D.C., Naini A., Hunot S., Vila M., Jackson-Lewis V., and Przedborski S. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl. Acad. Sci. USA 100 (2003) 5473-5478
263. Thomas M.J., Malenka R.C., and Bonci A. Modulation of long-term depression by dopamine in the mesolimbic system. J. Neurosci. 20 (2000) 5581-5586
264. Trabace L., and Kendrick K.M. Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. J. Neurochem. 75 (2000) 1664-1674
265. Uchida S., Akaike N., and Nabekura J. Dopamine activates inward rectifier K+ channel in acutely dissociated rat substantia nigra neurones. Neuropharmacology 39 (2000) 191-201
266. Vial D., and Piomelli D. Dopamine D2 receptors potentiate arachidonate release via activation of cytosolic, arachidonate-specific phospholipase A2. J. Neurochem. 64 (1995) 2765-2772
267. von Coelln R., Kugler S., Bahr M., Weller M., Dichgans J., and Schulz J.B. Rescue from death but not from functional impairment: Caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. J. Neurochem. 77 (2001) 263-273
268. Walters C.L., Kuo Y.C., and Blendy J.A. Differential distribution of CREB in the mesolimbic dopamine reward pathway. J. Neurochem. 87 (2003) 1237-1244
269. Wang H., and Pickel V.M. Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J. Comp. Neurol. 442 (2002) 392-404
270. Wang J., and O'Donnell P. D(1) dopamine receptors potentiate NMDA-mediated excitability increase in layer V prefrontal cortical pyramidal neurons. Cereb. Cortex. 11 (2001) 452-462
271. Wang Q., Jolly J.P., Surmeier J.D., Mullah B.M., Lidow M.S., Bergson C.M., and Robishaw J.D. Differential dependence of the D1 and D5 dopamine receptors on the G protein gamma 7 subunit for activation of adenylylcyclase. J. Biol. Chem. 276 (2001) 39386-39393
272. Wang X., Zhong P., Gu Z., and Yan Z. Regulation of NMDA receptors by dopamine D4 signaling in prefrontal cortex. J. Neurosci. 23 (2003) 9852-9861
273. Wedzony K., Chocyk A., Mackowiak M., Fijal K., and Czyrak A. Cortical localization of dopamine D4 receptors in the rat brain-immunocytochemical study. J. Physiol. Pharmacol. 51 (2000) 205-221
274. Wegener G., Volke V., and Rosenberg R. Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br. J. Pharmacol. 130 (2000) 575-580
275. West A.R., Galloway M.P., and Grace A.A. Regulation of striatal dopamine neurotransmission by nitric oxide: Effector pathways and signaling mechanisms. Synapse 44 (2002) 227-245
276. West A.R., and Grace A.A. Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo. J. Neurophysiol. 83 (2000) 1796-1808
277. Williams S.M., and Goldman-Rakic P.S. Widespread origin of the primate mesofrontal dopamine system. Cereb. Cortex. 8 (1998) 321-345
278. Wong A.C., Shetreat M.E., Clarke J.O., and Rayport S. D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro. Neuroscience 89 (1999) 221-233
279. Xia X.G., Schmidt N., Teismann P., Ferger B., and Schulz J.B. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation. J. Neurochem. 79 (2001) 63-70
280. Yan Z., Feng J., Fienberg A.A., and Greengard P. D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc. Natl. Acad. Sci. USA 96 (1999) 11607-11612
281. Yang S.N. Presynaptic involvement of nitric oxide in dopamine D1/D5 receptor-induced sustained enhancement of synaptic currents mediated by inotropic glutamate receptors in the rat hippocampus. Neurosci. Lett. 270 (1999) 87-90
282. Yoo M.S., Chun H.S., Son J.J., De Giorgio L.A., Kim D.J., Peng C., and Son J.H. Oxidative stress regulated genes in nigral dopaminergic neuronal cells: Correlation with the known pathology in Parkinson's disease. Brain Res. Mol. Brain Res. 110 (2003) 76-84
283. 2+ potentials via differential protein kinase A and C activation in rat prefrontal cortical neurons. J. Neurosci. 24 (2004) 8-23
284. Yung K.K., Bolam J.P., Smith A.D., Hersch S.M., Ciliax B.J., and Levey A.I. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy. Neuroscience 65 (1995) 709-730
285. Zhang J., Price J.O., Graham D.G., and Montine T.J. Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures. Biochem. Biophys. Res. Commun. 248 (1998) 812-816
286. Zoli M., Torri C., Ferrari R., Jansson A., Zini I., Fuxe K., and Agnati L.F. The emergence of the volume transmission concept. Brain Res. Brain Res. Rev. 26 (1998) 136-141